Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Rx for Parkinson's disease from NeuroSearch/BMS enters phase II

Nov. 15, 1996

Safer, more potent antipsychotic agents reported by HMR

Nov. 15, 1996

New antidepressants with improved safety reported by BMS

Nov. 15, 1996

Dutch researcher reports potential CNS agents

Nov. 15, 1996

Antipsychotic agents from Taisho

Nov. 15, 1996

New light shed on an old drug: Morphine and its mechanism of action

Nov. 15, 1996

Fujisawa transfers rights to analgesic product to Roxane

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

New NK1 antagonists claimed by Takeda

Nov. 15, 1996

Cortech announces further delays in development of Bradycor

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...